WO2013030838A3 - Dendrimer-lyotropic liquid crystal (llc) systems - Google Patents

Dendrimer-lyotropic liquid crystal (llc) systems Download PDF

Info

Publication number
WO2013030838A3
WO2013030838A3 PCT/IL2012/050336 IL2012050336W WO2013030838A3 WO 2013030838 A3 WO2013030838 A3 WO 2013030838A3 IL 2012050336 W IL2012050336 W IL 2012050336W WO 2013030838 A3 WO2013030838 A3 WO 2013030838A3
Authority
WO
WIPO (PCT)
Prior art keywords
llc
systems
liquid crystal
dendrimer
lyotropic liquid
Prior art date
Application number
PCT/IL2012/050336
Other languages
French (fr)
Other versions
WO2013030838A2 (en
Inventor
Nissim Garti
Dima Libster
Liron BITAN-CHERBACHOVSKY
Abraham Aserin
Original Assignee
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. filed Critical Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.
Publication of WO2013030838A2 publication Critical patent/WO2013030838A2/en
Publication of WO2013030838A3 publication Critical patent/WO2013030838A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

This invention relates to novel complex dendrimer-lyotropic liquid crystal (LLC) systems and uses thereof.
PCT/IL2012/050336 2011-08-29 2012-08-29 Dendrimer-lyotropic liquid crystal (llc) systems WO2013030838A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161528404P 2011-08-29 2011-08-29
US61/528,404 2011-08-29

Publications (2)

Publication Number Publication Date
WO2013030838A2 WO2013030838A2 (en) 2013-03-07
WO2013030838A3 true WO2013030838A3 (en) 2013-07-11

Family

ID=47019124

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2012/050336 WO2013030838A2 (en) 2011-08-29 2012-08-29 Dendrimer-lyotropic liquid crystal (llc) systems

Country Status (1)

Country Link
WO (1) WO2013030838A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722462B2 (en) 2014-12-10 2020-07-28 Council Of Scientific And Industrial Research Discontinuous reverse micellar composition in cubic FD3M phase for sustained release of therapeutic drugs
SG11201705155SA (en) * 2014-12-23 2017-07-28 Camurus Ab Controlled-release formulations
CN117563570B (en) * 2024-01-16 2024-03-15 西安金沃泰环保科技有限公司 Resin for protein adsorption and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050168663A1 (en) * 2003-12-18 2005-08-04 Sharp Kabushiki Kaisha Display element and display device, driving method of display element, and program

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070176143A1 (en) 2003-12-31 2007-08-02 Yissym Research Development Company Of The Hebrew University Of Jerusalem Stable ill-defined cubic nanosized particles in a ternary aqueous phase
EP2498754B1 (en) 2009-06-25 2018-06-06 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Reverse hexagonal mesophases (h ii) and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050168663A1 (en) * 2003-12-18 2005-08-04 Sharp Kabushiki Kaisha Display element and display device, driving method of display element, and program

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FRIBERG S E ET AL: "A NON-AQUEOUS LYOTROPIC LIQUID CRYSTAL WITH A STARBURST DENDRIMER AS A SOLVENT", MOLECULAR CRYSTALS AND LIQUID CRYSTALS(INC. NONLINEAR OPTICS ), GORDON AND BREACH SCIENCE PUBLISHERS, READING, GB, vol. 164, 1 November 1988 (1988-11-01), pages 157 - 165, XP000008357 *

Also Published As

Publication number Publication date
WO2013030838A2 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
GB2506473B (en) Display systems
EP2757139A4 (en) Compound, liquid crystal composition and liquid crystal display element
EP2734889A4 (en) Compact see-through display system
EP2555026B8 (en) Display device
EP2741125A4 (en) Liquid crystal module
EP2680070A4 (en) Display device
WO2013030838A3 (en) Dendrimer-lyotropic liquid crystal (llc) systems
EP2817724B8 (en) Input decoder
AU2011901504A0 (en) Display System
AU2011100323A4 (en) TagOwna Systems
AU2011900695A0 (en) C/C Vermon stopper
AU2012903790A0 (en) I spell MY words
AU2011901963A0 (en) Advertising systems
AU2011903059A0 (en) System of Rewards based on Popularity
AU2011902728A0 (en) Ship navigation display
AU2011902757A0 (en) Liquid chemical composition
AU2012902385A0 (en) Crystal Perfume
AU2012900363A0 (en) Display System
AU2011901470A0 (en) Liquid display device
AU2011903815A0 (en) Signage system
AU2011900733A0 (en) Mcas
AU2011901240A0 (en) Advertising system
AU2011905010A0 (en) Reciept Card
GB201110668D0 (en) Improved display systems
AU2011900512A0 (en) Advertising System

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12772815

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12772815

Country of ref document: EP

Kind code of ref document: A2